🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Syra Health wins North Carolina nursing contract

EditorAhmed Abdulazez Abdulkadir
Published 06/12/2024, 11:50 AM
SYRA
-

CARMEL, Ind. - Syra Health Corp. (NASDAQ: SYRA), a healthcare technology firm, has secured a one-year contract to provide nursing services to the North Carolina Department of Public Safety's Division of Juvenile Justice and Delinquency Prevention, with the option for two additional one-year renewals.

The contract entails supplying temporary nursing staff, including registered nurses, licensed practical nurses, medical technicians, and certified nursing assistants, to Youth Development Centers and Juvenile Detention Centers throughout North Carolina. This staffing solution aims to address the medical needs of youth under the department's care.

Syra Health's clinical healthcare staff will be tasked with screening and evaluating the health of youth upon their admission, crafting healthcare plans, and delivering necessary interventions. The revenue from this contract will depend on the number of positions filled and the duration of each assignment.

Dr. Deepika Vuppalanchi, CEO of Syra Health, expressed the company's commitment to providing high-quality care and support nationwide, stating, "We are honored to work with government agencies to provide essential healthcare services."

Syra Health focuses on delivering healthcare technologies that improve health outcomes in areas such as behavioral and mental health, digital health, and population health. Their solutions emphasize prevention, improved access, and affordable care.

In other recent news, Syra Health Corp. continues to expand its reach, securing several significant contracts across the nation. The healthcare technology firm has been awarded a contract by the Health Care Authority in Washington State to provide behavioral health and recovery training and support services. This agreement extends the company's operations to 20 states.

Furthermore, Syra Health has secured a contract to offer Special Education Psychologist Services to the Greenville County School District in South Carolina, enhancing support for students' academic, social, and emotional needs. In addition, the company has joined a $43 billion contract with the Defense Health Agency (DHA) as a subcontractor for LUKE to provide medical staffing services.

In Maine, Syra Health has been selected to create a health equity accelerator plan for the City of Portland, aimed at improving chronic disease outcomes among populations facing health disparities. Lastly, the company has been contracted to provide training for first responders and faith-based community organizations in Sedgwick County, Kansas, as part of the county's efforts to address substance use disorder.

InvestingPro Insights

In light of Syra Health's new contract with the North Carolina Department of Public Safety, investors may consider several financial metrics and InvestingPro Tips to assess the company's current position. With a market capitalization of $23.11 million, Syra Health is a relatively small player in the healthcare technology sector. The company's Price / Book ratio over the last twelve months as of Q1 2024 stands at 6.7, indicating that the market values the company significantly higher than its net asset value, which could reflect investor expectations for future growth.

An important aspect to note is that Syra Health is currently not profitable, with a negative P/E ratio of -2.12, and analysts do not expect the company to be profitable this year. However, the InvestingPro Tips highlight that Syra Health holds more cash than debt on its balance sheet and has liquid assets exceeding its short-term obligations, providing some financial stability and flexibility.

From a performance perspective, Syra Health has experienced a significant return over the last week, with a 17.15% increase, and a strong return over the last month at 15.28%. This recent uptrend may be reflective of positive investor sentiment following the announcement of the new contract, although it's crucial to note that the company's net income is expected to drop this year.

For investors looking for a more in-depth analysis, there are additional InvestingPro Tips available for Syra Health, which can be found at Investing.com/pro/SYRA. For those interested in a subscription, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. With 10 total tips listed in InvestingPro, investors can gain a comprehensive understanding of the company's financial health and future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.